Rank | Gene Set | Z-score |
---|---|---|
1 | sequestering of actin monomers (GO:0042989) | 6.80027791 |
2 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 5.67258736 |
3 | neutrophil activation involved in immune response (GO:0002283) | 4.85316127 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.65975852 |
5 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.42392188 |
6 | thrombin receptor signaling pathway (GO:0070493) | 4.20042454 |
7 | positive regulation of mast cell activation (GO:0033005) | 4.16921685 |
8 | microglial cell activation (GO:0001774) | 4.06122697 |
9 | aggressive behavior (GO:0002118) | 3.96990443 |
10 | regulation of platelet aggregation (GO:0090330) | 3.96308392 |
11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.90593566 |
12 | negative regulation of cell killing (GO:0031342) | 3.90593566 |
13 | modulation by symbiont of host immune response (GO:0052553) | 3.84363782 |
14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84363782 |
15 | modulation by symbiont of host defense response (GO:0052031) | 3.84363782 |
16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84363782 |
17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84363782 |
18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84363782 |
19 | regulation of platelet activation (GO:0010543) | 3.75334721 |
20 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.65760736 |
21 | myeloid cell activation involved in immune response (GO:0002275) | 3.55013394 |
22 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.53286020 |
23 | positive regulation of macrophage differentiation (GO:0045651) | 3.53136901 |
24 | macrophage activation involved in immune response (GO:0002281) | 3.53083433 |
25 | platelet aggregation (GO:0070527) | 3.47407670 |
26 | lipoxygenase pathway (GO:0019372) | 3.45384528 |
27 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.44676874 |
28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.44665429 |
29 | negative regulation of norepinephrine secretion (GO:0010700) | 3.40729954 |
30 | B cell mediated immunity (GO:0019724) | 3.40424491 |
31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36649396 |
32 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.33709473 |
33 | positive regulation of B cell mediated immunity (GO:0002714) | 3.32626901 |
34 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.32626901 |
35 | behavioral response to pain (GO:0048266) | 3.32139730 |
36 | angiogenesis involved in wound healing (GO:0060055) | 3.30862146 |
37 | positive regulation of mast cell degranulation (GO:0043306) | 3.28149436 |
38 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.28149436 |
39 | regulation of T cell tolerance induction (GO:0002664) | 3.27216301 |
40 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.25837301 |
41 | negative regulation of interleukin-12 production (GO:0032695) | 3.23281682 |
42 | respiratory burst (GO:0045730) | 3.23005082 |
43 | protein neddylation (GO:0045116) | 3.22520921 |
44 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.22015644 |
45 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18952125 |
46 | positive regulation of B cell differentiation (GO:0045579) | 3.18728506 |
47 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.17570995 |
48 | granulocyte activation (GO:0036230) | 3.16797570 |
49 | peripheral nervous system neuron development (GO:0048935) | 3.15311744 |
50 | adenosine receptor signaling pathway (GO:0001973) | 3.14857174 |
51 | response to acidic pH (GO:0010447) | 3.13868226 |
52 | megakaryocyte development (GO:0035855) | 3.13795506 |
53 | positive regulation of isotype switching (GO:0045830) | 3.09525441 |
54 | mast cell activation (GO:0045576) | 3.08977343 |
55 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.08350896 |
56 | leukocyte degranulation (GO:0043299) | 3.08282642 |
57 | neutrophil activation (GO:0042119) | 3.07424382 |
58 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.07237461 |
59 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05480057 |
60 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.02839581 |
61 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.02839581 |
62 | regulation of monocyte chemotaxis (GO:0090025) | 3.02024207 |
63 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.01281242 |
64 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01195591 |
65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.00709864 |
66 | response to peptidoglycan (GO:0032494) | 3.00362305 |
67 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98810401 |
68 | negative regulation of T cell apoptotic process (GO:0070233) | 2.98688626 |
69 | positive regulation of granulocyte differentiation (GO:0030854) | 2.98154351 |
70 | cytidine catabolic process (GO:0006216) | 2.96958229 |
71 | cytidine deamination (GO:0009972) | 2.96958229 |
72 | cytidine metabolic process (GO:0046087) | 2.96958229 |
73 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.96872629 |
74 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.96804682 |
75 | detection of temperature stimulus (GO:0016048) | 2.96131498 |
76 | positive regulation of interferon-alpha production (GO:0032727) | 2.95486618 |
77 | actin nucleation (GO:0045010) | 2.93467528 |
78 | chaperone-mediated protein transport (GO:0072321) | 2.93307292 |
79 | positive regulation of antigen processing and presentation (GO:0002579) | 2.92990703 |
80 | negative thymic T cell selection (GO:0045060) | 2.92838157 |
81 | regulation of penile erection (GO:0060405) | 2.92628991 |
82 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.90971026 |
83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.90971026 |
84 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.89639049 |
85 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89040406 |
86 | negative T cell selection (GO:0043383) | 2.88992799 |
87 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.88277738 |
88 | purinergic receptor signaling pathway (GO:0035587) | 2.86195912 |
89 | neuronal action potential propagation (GO:0019227) | 2.85865432 |
90 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.84716685 |
91 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.83980287 |
92 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.83176987 |
93 | tolerance induction (GO:0002507) | 2.82340198 |
94 | erythrocyte maturation (GO:0043249) | 2.81699037 |
95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81565437 |
96 | regulation of interferon-alpha production (GO:0032647) | 2.81179065 |
97 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80955195 |
98 | regulation of interleukin-17 production (GO:0032660) | 2.80932194 |
99 | negative regulation of cation channel activity (GO:2001258) | 2.79265983 |
100 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.79234679 |
101 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.79234679 |
102 | regulation of chronic inflammatory response (GO:0002676) | 2.78918331 |
103 | phagosome maturation (GO:0090382) | 2.78055854 |
104 | positive regulation of DNA recombination (GO:0045911) | 2.77180324 |
105 | membrane raft organization (GO:0031579) | 2.76899885 |
106 | regulation of mast cell activation (GO:0033003) | 2.74662016 |
107 | cellular response to interferon-beta (GO:0035458) | 2.73993712 |
108 | regulation of leukocyte degranulation (GO:0043300) | 2.73871932 |
109 | autophagic vacuole fusion (GO:0000046) | 2.73648020 |
110 | mast cell degranulation (GO:0043303) | 2.73623457 |
111 | mast cell activation involved in immune response (GO:0002279) | 2.73623457 |
112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.73567393 |
113 | negative regulation of mast cell activation (GO:0033004) | 2.72675146 |
114 | T cell costimulation (GO:0031295) | 2.71941080 |
115 | regulation of integrin activation (GO:0033623) | 2.71284380 |
116 | myeloid dendritic cell differentiation (GO:0043011) | 2.70954477 |
117 | response to water (GO:0009415) | 2.70798335 |
118 | lymphocyte costimulation (GO:0031294) | 2.70412626 |
119 | negative regulation of platelet activation (GO:0010544) | 2.69109578 |
120 | cellular extravasation (GO:0045123) | 2.68767113 |
121 | negative regulation of interleukin-17 production (GO:0032700) | 2.68733156 |
122 | regulation of B cell mediated immunity (GO:0002712) | 2.67812618 |
123 | regulation of B cell differentiation (GO:0045577) | 2.67681452 |
124 | T cell migration (GO:0072678) | 2.66539633 |
125 | positive regulation of interleukin-17 production (GO:0032740) | 2.66230877 |
126 | response to host immune response (GO:0052572) | 2.66213022 |
127 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66213022 |
128 | T cell proliferation (GO:0042098) | 2.66011100 |
129 | myeloid dendritic cell activation (GO:0001773) | 2.65264855 |
130 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.64573764 |
131 | B cell receptor signaling pathway (GO:0050853) | 2.63821055 |
132 | macrophage activation (GO:0042116) | 2.63685863 |
133 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.62223488 |
134 | leukocyte mediated cytotoxicity (GO:0001909) | 2.61969654 |
135 | regulation of dopamine secretion (GO:0014059) | 2.61929443 |
136 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.61868215 |
137 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.59954924 |
138 | homotypic cell-cell adhesion (GO:0034109) | 2.59767882 |
139 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.59431417 |
140 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.57666738 |
141 | myeloid leukocyte activation (GO:0002274) | 2.57603035 |
142 | negative regulation of heart rate (GO:0010459) | 2.55826117 |
143 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.55737880 |
144 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.54992571 |
145 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.54939895 |
146 | positive regulation of type 2 immune response (GO:0002830) | 2.54737652 |
147 | positive thymic T cell selection (GO:0045059) | 2.53537723 |
148 | immunoglobulin mediated immune response (GO:0016064) | 2.53241111 |
149 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.52850091 |
150 | response to pain (GO:0048265) | 2.52748186 |
151 | regulation of mast cell degranulation (GO:0043304) | 2.51910014 |
152 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.51019554 |
153 | regulation of antigen processing and presentation (GO:0002577) | 2.50731806 |
154 | transferrin transport (GO:0033572) | 2.50256260 |
155 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.47906548 |
156 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.47906548 |
157 | dendritic cell differentiation (GO:0097028) | 2.45679076 |
158 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.45553543 |
159 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.45020573 |
160 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.44442442 |
161 | negative regulation of granulocyte differentiation (GO:0030853) | 2.43249169 |
162 | negative regulation of catecholamine secretion (GO:0033604) | 2.41828329 |
163 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.40389548 |
164 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.37452896 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.78854185 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.62477057 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.86287692 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.19636796 |
5 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.06633539 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.59229733 |
7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.38701789 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.09757242 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01106286 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95621325 |
11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.69288264 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51735031 |
13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49303187 |
14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.47784564 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.45630949 |
16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.35313617 |
17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.29532264 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.28144525 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26673645 |
20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.20850408 |
21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.17560451 |
22 | GATA1_19941826_ChIP-Seq_K562_Human | 2.12745631 |
23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07000711 |
24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97096918 |
25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.94616058 |
26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.92111082 |
27 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.90127500 |
28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86806910 |
29 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.85086805 |
30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.83398703 |
31 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.73249574 |
32 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.71722743 |
33 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71644212 |
34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.71565683 |
35 | GATA2_19941826_ChIP-Seq_K562_Human | 1.70603855 |
36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69362614 |
37 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.69242449 |
38 | * MYC_22102868_ChIP-Seq_BL_Human | 1.67935074 |
39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67445773 |
40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66204987 |
41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.64912318 |
42 | MYB_26560356_Chip-Seq_TH2_Human | 1.61049327 |
43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52948981 |
44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.49990847 |
45 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.49762593 |
46 | MAF_26560356_Chip-Seq_TH1_Human | 1.49414270 |
47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47829825 |
48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46902509 |
49 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.41102556 |
50 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.40074838 |
51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38018062 |
52 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37801943 |
53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32894192 |
54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32633493 |
55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30657063 |
56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30169322 |
57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29866584 |
58 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.26306859 |
59 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25702868 |
60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25613439 |
61 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.25590901 |
62 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.24512240 |
63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22436938 |
64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21304498 |
65 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.21188927 |
66 | MAF_26560356_Chip-Seq_TH2_Human | 1.20242800 |
67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20099077 |
68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17796199 |
69 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.16594168 |
70 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.16539904 |
71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15822726 |
72 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13090892 |
73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.12888854 |
74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12604430 |
75 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12085898 |
76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11831162 |
77 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.09677450 |
78 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09487690 |
79 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08961121 |
80 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.08935763 |
81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08808634 |
82 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.08654795 |
83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07847798 |
84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07294879 |
85 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05426953 |
86 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04755357 |
87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04221723 |
88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03420940 |
89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02848136 |
90 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.02788932 |
91 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02694549 |
92 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01371421 |
93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01067481 |
94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00481919 |
95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00264837 |
96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.00035794 |
97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98426738 |
98 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98360809 |
99 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.97687950 |
100 | MYB_26560356_Chip-Seq_TH1_Human | 0.97663698 |
101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95576544 |
102 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.95509013 |
103 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.94317480 |
104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93910959 |
105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92621866 |
106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91931681 |
107 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90793262 |
108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90483126 |
109 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90337509 |
110 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.89841259 |
111 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89312522 |
112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.87738574 |
113 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87436214 |
114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86842389 |
115 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86562164 |
116 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85495948 |
117 | UTX_26944678_Chip-Seq_JUKART_Human | 0.85400071 |
118 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.85286733 |
119 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.85117888 |
120 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.85117888 |
121 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84786579 |
122 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83729730 |
123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83661461 |
124 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.83523057 |
125 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.83366058 |
126 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83353044 |
127 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82774115 |
128 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82609905 |
129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82440213 |
130 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.79521414 |
131 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.79037523 |
132 | P300_27268052_Chip-Seq_Bcells_Human | 0.78707850 |
133 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.78391139 |
134 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77717835 |
135 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76655244 |
136 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76284882 |
137 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.75984619 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002735_abnormal_chemical_nociception | 3.92748870 |
2 | MP0001835_abnormal_antigen_presentation | 3.90750552 |
3 | MP0001968_abnormal_touch/_nociception | 3.27688699 |
4 | MP0002736_abnormal_nociception_after | 3.25036583 |
5 | MP0005671_abnormal_response_to | 2.99575090 |
6 | MP0002148_abnormal_hypersensitivity_rea | 2.96246036 |
7 | MP0006082_CNS_inflammation | 2.90384253 |
8 | MP0008004_abnormal_stomach_pH | 2.89176760 |
9 | MP0004510_myositis | 2.66426735 |
10 | MP0001986_abnormal_taste_sensitivity | 2.63914417 |
11 | MP0005000_abnormal_immune_tolerance | 2.61531087 |
12 | MP0002733_abnormal_thermal_nociception | 2.47942635 |
13 | MP0001970_abnormal_pain_threshold | 2.40425343 |
14 | MP0000465_gastrointestinal_hemorrhage | 2.33044640 |
15 | MP0005058_abnormal_lysosome_morphology | 2.29404979 |
16 | MP0003436_decreased_susceptibility_to | 2.28754000 |
17 | MP0005387_immune_system_phenotype | 2.20908528 |
18 | MP0001790_abnormal_immune_system | 2.20908528 |
19 | MP0001800_abnormal_humoral_immune | 2.15047939 |
20 | MP0009785_altered_susceptibility_to | 2.14716751 |
21 | MP0002419_abnormal_innate_immunity | 2.10131094 |
22 | MP0004859_abnormal_synaptic_plasticity | 2.07733726 |
23 | MP0000685_abnormal_immune_system | 2.07135812 |
24 | MP0002723_abnormal_immune_serum | 2.06863966 |
25 | MP0003724_increased_susceptibility_to | 2.05267902 |
26 | MP0002452_abnormal_antigen_presenting | 2.03378962 |
27 | MP0002734_abnormal_mechanical_nocicepti | 2.01516460 |
28 | MP0003303_peritoneal_inflammation | 1.95704280 |
29 | MP0004270_analgesia | 1.95640546 |
30 | MP0005025_abnormal_response_to | 1.92346295 |
31 | MP0001819_abnormal_immune_cell | 1.92164510 |
32 | MP0003172_abnormal_lysosome_physiology | 1.91769167 |
33 | MP0002420_abnormal_adaptive_immunity | 1.90097942 |
34 | MP0003183_abnormal_peptide_metabolism | 1.88736340 |
35 | MP0005464_abnormal_platelet_physiology | 1.87281602 |
36 | MP0005310_abnormal_salivary_gland | 1.78320918 |
37 | MP0002163_abnormal_gland_morphology | 1.74285710 |
38 | MP0002064_seizures | 1.64608327 |
39 | MP0002166_altered_tumor_susceptibility | 1.62887178 |
40 | MP0004858_abnormal_nervous_system | 1.58866657 |
41 | MP0002405_respiratory_system_inflammati | 1.56319326 |
42 | MP0003763_abnormal_thymus_physiology | 1.49423276 |
43 | MP0002398_abnormal_bone_marrow | 1.48586608 |
44 | MP0006276_abnormal_autonomic_nervous | 1.46380670 |
45 | MP0003828_pulmonary_edema | 1.45369874 |
46 | MP0002006_tumorigenesis | 1.43463878 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 1.43296657 |
48 | MP0009333_abnormal_splenocyte_physiolog | 1.42656698 |
49 | * MP0000716_abnormal_immune_system | 1.40223063 |
50 | MP0005397_hematopoietic_system_phenotyp | 1.39807304 |
51 | MP0001545_abnormal_hematopoietic_system | 1.39807304 |
52 | MP0003806_abnormal_nucleotide_metabolis | 1.35291325 |
53 | MP0003191_abnormal_cellular_cholesterol | 1.31914605 |
54 | MP0002277_abnormal_respiratory_mucosa | 1.31605220 |
55 | MP0000689_abnormal_spleen_morphology | 1.30964139 |
56 | MP0001845_abnormal_inflammatory_respons | 1.29389903 |
57 | MP0001348_abnormal_lacrimal_gland | 1.25411231 |
58 | MP0001853_heart_inflammation | 1.23436714 |
59 | MP0003880_abnormal_central_pattern | 1.22994029 |
60 | MP0009763_increased_sensitivity_to | 1.21860961 |
61 | MP0002722_abnormal_immune_system | 1.21643310 |
62 | MP0001873_stomach_inflammation | 1.21132948 |
63 | MP0003635_abnormal_synaptic_transmissio | 1.20931818 |
64 | MP0009745_abnormal_behavioral_response | 1.18687781 |
65 | MP0001533_abnormal_skeleton_physiology | 1.17797551 |
66 | MP0002822_catalepsy | 1.17166394 |
67 | MP0003866_abnormal_defecation | 1.16349010 |
68 | MP0009046_muscle_twitch | 1.15551277 |
69 | MP0002067_abnormal_sensory_capabilities | 1.14790103 |
70 | MP0000604_amyloidosis | 1.11896088 |
71 | MP0002877_abnormal_melanocyte_morpholog | 1.11546242 |
72 | MP0008469_abnormal_protein_level | 1.11257152 |
73 | MP0003448_altered_tumor_morphology | 1.10611562 |
74 | MP0002132_abnormal_respiratory_system | 1.09926460 |
75 | * MP0002429_abnormal_blood_cell | 1.09154930 |
76 | MP0002272_abnormal_nervous_system | 1.08340611 |
77 | MP0008874_decreased_physiological_sensi | 1.04653235 |
78 | MP0000249_abnormal_blood_vessel | 1.02176889 |
79 | MP0005379_endocrine/exocrine_gland_phen | 1.01219241 |
80 | MP0005083_abnormal_biliary_tract | 1.00513398 |
81 | MP0000490_abnormal_crypts_of | 0.99174944 |
82 | MP0005167_abnormal_blood-brain_barrier | 0.98754337 |
83 | MP0009379_abnormal_foot_pigmentation | 0.98272791 |
84 | MP0002184_abnormal_innervation | 0.96407016 |
85 | MP0000015_abnormal_ear_pigmentation | 0.95787830 |
86 | MP0002090_abnormal_vision | 0.95555057 |
87 | MP0009278_abnormal_bone_marrow | 0.95206354 |
88 | MP0002638_abnormal_pupillary_reflex | 0.93330155 |
89 | MP0005165_increased_susceptibility_to | 0.93251539 |
90 | MP0002572_abnormal_emotion/affect_behav | 0.92837415 |
91 | MP0009765_abnormal_xenobiotic_induced | 0.92625273 |
92 | MP0003075_altered_response_to | 0.92450981 |
93 | MP0003566_abnormal_cell_adhesion | 0.92297849 |
94 | MP0004811_abnormal_neuron_physiology | 0.88346412 |
95 | MP0009840_abnormal_foam_cell | 0.88186239 |
96 | MP0003638_abnormal_response/metabolism_ | 0.87543355 |
97 | MP0004947_skin_inflammation | 0.85681343 |
98 | MP0002396_abnormal_hematopoietic_system | 0.83926613 |
99 | MP0005166_decreased_susceptibility_to | 0.83554367 |
100 | MP0003453_abnormal_keratinocyte_physiol | 0.83421981 |
101 | MP0001440_abnormal_grooming_behavior | 0.83145507 |
102 | MP0000343_altered_response_to | 0.81846597 |
103 | MP0000703_abnormal_thymus_morphology | 0.81668944 |
104 | MP0005451_abnormal_body_composition | 0.81554983 |
105 | MP0000230_abnormal_systemic_arterial | 0.81242456 |
106 | MP0000858_altered_metastatic_potential | 0.81183649 |
107 | MP0003045_fibrosis | 0.80050876 |
108 | MP0005410_abnormal_fertilization | 0.79660082 |
109 | MP0002876_abnormal_thyroid_physiology | 0.79653362 |
110 | MP0004381_abnormal_hair_follicle | 0.79415943 |
111 | MP0003300_gastrointestinal_ulcer | 0.78301009 |
112 | MP0004808_abnormal_hematopoietic_stem | 0.78233057 |
113 | MP0001851_eye_inflammation | 0.76987745 |
114 | MP0005174_abnormal_tail_pigmentation | 0.76545095 |
115 | MP0003186_abnormal_redox_activity | 0.76065329 |
116 | MP0005075_abnormal_melanosome_morpholog | 0.75623701 |
117 | MP0000920_abnormal_myelination | 0.75276727 |
118 | MP0001663_abnormal_digestive_system | 0.74754780 |
119 | MP0008260_abnormal_autophagy | 0.74072323 |
120 | MP0005381_digestive/alimentary_phenotyp | 0.73870061 |
121 | MP0000372_irregular_coat_pigmentation | 0.73850556 |
122 | MP0003879_abnormal_hair_cell | 0.73263104 |
123 | MP0010155_abnormal_intestine_physiology | 0.72972632 |
124 | MP0006054_spinal_hemorrhage | 0.72814574 |
125 | MP0006036_abnormal_mitochondrial_physio | 0.71123488 |
126 | MP0002063_abnormal_learning/memory/cond | 0.69079222 |
127 | MP0005390_skeleton_phenotype | 0.68990007 |
128 | MP0009764_decreased_sensitivity_to | 0.68957201 |
129 | MP0004142_abnormal_muscle_tone | 0.68546885 |
130 | MP0002998_abnormal_bone_remodeling | 0.68037294 |
131 | MP0001270_distended_abdomen | 0.67748327 |
132 | MP0002019_abnormal_tumor_incidence | 0.67235164 |
133 | MP0004883_abnormal_blood_vessel | 0.66829320 |
134 | MP0005084_abnormal_gallbladder_morpholo | 0.64784688 |
135 | * MP0003795_abnormal_bone_structure | 0.64541459 |
136 | MP0005023_abnormal_wound_healing | 0.63161245 |
137 | MP0002138_abnormal_hepatobiliary_system | 0.60054660 |
138 | MP0008872_abnormal_physiological_respon | 0.59912275 |
139 | * MP0009642_abnormal_blood_homeostasis | 0.58291805 |
140 | MP0005164_abnormal_response_to | 0.57484664 |
141 | MP0004036_abnormal_muscle_relaxation | 0.54146736 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Menorrhagia (HP:0000132) | 6.41884107 |
2 | Increased mean platelet volume (HP:0011877) | 6.29290787 |
3 | Abnormal platelet volume (HP:0011876) | 6.22783388 |
4 | Myokymia (HP:0002411) | 6.07033556 |
5 | Epistaxis (HP:0000421) | 5.91121887 |
6 | Systemic lupus erythematosus (HP:0002725) | 4.94569374 |
7 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.79729115 |
8 | Gingival bleeding (HP:0000225) | 4.78822418 |
9 | Recurrent abscess formation (HP:0002722) | 4.44588353 |
10 | Spontaneous hematomas (HP:0007420) | 4.32758956 |
11 | Impaired platelet aggregation (HP:0003540) | 4.30300647 |
12 | Abnormal platelet function (HP:0011869) | 4.30300647 |
13 | Abnormality of glycolipid metabolism (HP:0010969) | 4.24960636 |
14 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.24960636 |
15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.24960636 |
16 | Eczematoid dermatitis (HP:0000976) | 3.99334290 |
17 | Recurrent bacterial skin infections (HP:0005406) | 3.97930826 |
18 | Glomerulonephritis (HP:0000099) | 3.73127912 |
19 | Hyperlipoproteinemia (HP:0010980) | 3.66261137 |
20 | Increased cerebral lipofuscin (HP:0011813) | 3.44403944 |
21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.44252671 |
22 | Febrile seizures (HP:0002373) | 3.40449174 |
23 | Abnormality of macrophages (HP:0004311) | 3.39981274 |
24 | Myotonia (HP:0002486) | 3.36515360 |
25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.30525213 |
26 | Abnormal hair whorl (HP:0010721) | 3.29398022 |
27 | Popliteal pterygium (HP:0009756) | 3.25624574 |
28 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.23905266 |
29 | Vacuolated lymphocytes (HP:0001922) | 3.12228620 |
30 | Conjunctival telangiectasia (HP:0000524) | 3.07744826 |
31 | Encephalitis (HP:0002383) | 3.05554607 |
32 | Failure to thrive in infancy (HP:0001531) | 3.02738045 |
33 | Atonic seizures (HP:0010819) | 3.00151914 |
34 | T lymphocytopenia (HP:0005403) | 2.99561476 |
35 | Autoimmune hemolytic anemia (HP:0001890) | 2.94482912 |
36 | Increased IgM level (HP:0003496) | 2.85788216 |
37 | Obstructive lung disease (HP:0006536) | 2.80147107 |
38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.80147107 |
39 | Axonal loss (HP:0003447) | 2.74496075 |
40 | Paralysis (HP:0003470) | 2.72182098 |
41 | J-shaped sella turcica (HP:0002680) | 2.71601428 |
42 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.69777961 |
43 | Myositis (HP:0100614) | 2.66409027 |
44 | Mutism (HP:0002300) | 2.65985518 |
45 | Neuroendocrine neoplasm (HP:0100634) | 2.63781411 |
46 | Joint swelling (HP:0001386) | 2.56112356 |
47 | Dyschromatopsia (HP:0007641) | 2.54564299 |
48 | Increased serum ferritin (HP:0003281) | 2.54379578 |
49 | Recurrent fungal infections (HP:0002841) | 2.53003557 |
50 | Vasculitis (HP:0002633) | 2.52312479 |
51 | Poikilocytosis (HP:0004447) | 2.51893279 |
52 | Bruising susceptibility (HP:0000978) | 2.51446306 |
53 | Nephritis (HP:0000123) | 2.51428525 |
54 | Dysostosis multiplex (HP:0000943) | 2.49791209 |
55 | Pheochromocytoma (HP:0002666) | 2.47862875 |
56 | Abnormality of iron homeostasis (HP:0011031) | 2.47372219 |
57 | Sensory axonal neuropathy (HP:0003390) | 2.47095973 |
58 | Abnormality of the prostate (HP:0008775) | 2.46658505 |
59 | Retrobulbar optic neuritis (HP:0100654) | 2.46599492 |
60 | Optic neuritis (HP:0100653) | 2.46599492 |
61 | Hypothermia (HP:0002045) | 2.45452573 |
62 | Abnormality of T cells (HP:0002843) | 2.44077194 |
63 | Acute necrotizing encephalopathy (HP:0006965) | 2.43579131 |
64 | Arterial thrombosis (HP:0004420) | 2.42083918 |
65 | Abnormality of lateral ventricle (HP:0030047) | 2.42035520 |
66 | Recurrent skin infections (HP:0001581) | 2.38846947 |
67 | Chest pain (HP:0100749) | 2.35257847 |
68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31944023 |
69 | Acanthocytosis (HP:0001927) | 2.31090304 |
70 | Abnormality of the common coagulation pathway (HP:0010990) | 2.31023560 |
71 | Inflammation of the large intestine (HP:0002037) | 2.30912914 |
72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.30634985 |
73 | Upper motor neuron abnormality (HP:0002127) | 2.30177043 |
74 | Focal motor seizures (HP:0011153) | 2.30170875 |
75 | Petechiae (HP:0000967) | 2.29631562 |
76 | Eosinophilia (HP:0001880) | 2.27733183 |
77 | Gastrointestinal infarctions (HP:0005244) | 2.27393954 |
78 | Progressive macrocephaly (HP:0004481) | 2.26143398 |
79 | Focal seizures (HP:0007359) | 2.24888395 |
80 | Mediastinal lymphadenopathy (HP:0100721) | 2.24090486 |
81 | Orchitis (HP:0100796) | 2.23975092 |
82 | Pulmonary infiltrates (HP:0002113) | 2.22201392 |
83 | IgG deficiency (HP:0004315) | 2.22197074 |
84 | Stomatitis (HP:0010280) | 2.21288821 |
85 | Submucous cleft hard palate (HP:0000176) | 2.19080284 |
86 | Thrombocytosis (HP:0001894) | 2.18277113 |
87 | Complement deficiency (HP:0004431) | 2.17226623 |
88 | Ulnar claw (HP:0001178) | 2.16907413 |
89 | Abnormal pupillary function (HP:0007686) | 2.16518102 |
90 | Gastrointestinal inflammation (HP:0004386) | 2.16126063 |
91 | Increased density of long bones (HP:0006392) | 2.15932220 |
92 | Purpura (HP:0000979) | 2.15783988 |
93 | Progressive inability to walk (HP:0002505) | 2.15047699 |
94 | Granulocytopenia (HP:0001913) | 2.12412290 |
95 | Urticaria (HP:0001025) | 2.10972685 |
96 | Cerebral hemorrhage (HP:0001342) | 2.10958531 |
97 | Leukocytosis (HP:0001974) | 2.10829416 |
98 | Abnormality of eosinophils (HP:0001879) | 2.10103912 |
99 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10084486 |
100 | Recurrent viral infections (HP:0004429) | 2.10000498 |
101 | Mitochondrial inheritance (HP:0001427) | 2.09218627 |
102 | Prolonged bleeding time (HP:0003010) | 2.09140186 |
103 | Disinhibition (HP:0000734) | 2.08801147 |
104 | Thoracolumbar scoliosis (HP:0002944) | 2.08521182 |
105 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.07371551 |
106 | Abnormality of the vocal cords (HP:0008777) | 2.05570484 |
107 | Myocardial infarction (HP:0001658) | 2.05215361 |
108 | Hypergammaglobulinemia (HP:0010702) | 2.04542549 |
109 | Thyroiditis (HP:0100646) | 2.02549705 |
110 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.01569021 |
111 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01323103 |
112 | Basal ganglia calcification (HP:0002135) | 2.00504475 |
113 | Absence seizures (HP:0002121) | 2.00483963 |
114 | Chronic diarrhea (HP:0002028) | 2.00218995 |
115 | Abnormality of complement system (HP:0005339) | 2.00180988 |
116 | Polycythemia (HP:0001901) | 1.99900717 |
117 | Hemoptysis (HP:0002105) | 1.99397897 |
118 | Nausea (HP:0002018) | 1.97637105 |
119 | Gastrointestinal stroma tumor (HP:0100723) | 1.96927311 |
120 | Hypercortisolism (HP:0001578) | 1.96625330 |
121 | Pulmonary embolism (HP:0002204) | 1.96514367 |
122 | Distal arthrogryposis (HP:0005684) | 1.96175281 |
123 | Agnosia (HP:0010524) | 1.95755267 |
124 | Dialeptic seizures (HP:0011146) | 1.95652977 |
125 | Arthralgia (HP:0002829) | 1.95169587 |
126 | IgM deficiency (HP:0002850) | 1.95081420 |
127 | Episodic fever (HP:0001954) | 1.94500455 |
128 | IgA deficiency (HP:0002720) | 1.94121718 |
129 | Pustule (HP:0200039) | 1.94085513 |
130 | Abnormality of T cell physiology (HP:0011840) | 1.94005561 |
131 | Recurrent cutaneous fungal infections (HP:0011370) | 1.93475053 |
132 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.93475053 |
133 | Exertional dyspnea (HP:0002875) | 1.93387956 |
134 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.91679455 |
135 | Abnormal gallbladder physiology (HP:0012438) | 1.91382066 |
136 | Cholecystitis (HP:0001082) | 1.91382066 |
137 | Meningitis (HP:0001287) | 1.90998677 |
138 | Supranuclear gaze palsy (HP:0000605) | 1.90709163 |
139 | Gingivitis (HP:0000230) | 1.90517605 |
140 | Striae distensae (HP:0001065) | 1.89783290 |
141 | Gangrene (HP:0100758) | 1.89485115 |
142 | Mucosal telangiectasiae (HP:0100579) | 1.89187103 |
143 | Lymphopenia (HP:0001888) | 1.88571146 |
144 | Autoimmune thrombocytopenia (HP:0001973) | 1.87877304 |
145 | Neuronal loss in central nervous system (HP:0002529) | 1.87861525 |
146 | Keratoconjunctivitis sicca (HP:0001097) | 1.87056654 |
147 | Visual hallucinations (HP:0002367) | 1.86938043 |
148 | Postural tremor (HP:0002174) | 1.85231023 |
149 | Retinal atrophy (HP:0001105) | 1.84147109 |
150 | Peripheral hypomyelination (HP:0007182) | 1.79351246 |
151 | Hepatosplenomegaly (HP:0001433) | 1.78820838 |
152 | Progressive cerebellar ataxia (HP:0002073) | 1.78586368 |
153 | Panhypogammaglobulinemia (HP:0003139) | 1.77767895 |
154 | Action tremor (HP:0002345) | 1.74649416 |
155 | Hypokinesia (HP:0002375) | 1.74525747 |
156 | Epileptic encephalopathy (HP:0200134) | 1.74441221 |
157 | Abnormality of T cell number (HP:0011839) | 1.74287146 |
158 | Generalized tonic-clonic seizures (HP:0002069) | 1.73574675 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GRK5 | 5.45922424 |
2 | NME2 | 3.32622493 |
3 | MAP3K12 | 2.81896664 |
4 | ARAF | 2.74266338 |
5 | MAP4K1 | 2.60258507 |
6 | RIPK4 | 2.48127123 |
7 | PIM2 | 2.46215640 |
8 | BMX | 2.45426100 |
9 | BLK | 2.44724610 |
10 | TXK | 2.43061429 |
11 | TYK2 | 2.39647336 |
12 | MAP3K14 | 2.24506333 |
13 | LIMK1 | 2.13872114 |
14 | GRK7 | 2.11665541 |
15 | TBK1 | 2.10680001 |
16 | TGFBR2 | 2.05536930 |
17 | EIF2AK1 | 2.00967638 |
18 | ZAP70 | 1.89899854 |
19 | MAP3K9 | 1.82217538 |
20 | IRAK3 | 1.80675574 |
21 | MAP2K3 | 1.78629594 |
22 | TAOK2 | 1.75953207 |
23 | KSR2 | 1.72951230 |
24 | KIT | 1.71882477 |
25 | FGR | 1.70894397 |
26 | FES | 1.59750316 |
27 | PIK3CG | 1.58612803 |
28 | MAP3K2 | 1.55718228 |
29 | BMPR1B | 1.55536344 |
30 | SYK | 1.55276397 |
31 | IRAK4 | 1.53568763 |
32 | TESK1 | 1.50016093 |
33 | ILK | 1.47957162 |
34 | MAP3K11 | 1.47595056 |
35 | IKBKE | 1.45097351 |
36 | PTK2B | 1.44936246 |
37 | NTRK3 | 1.42778068 |
38 | JAK1 | 1.36148984 |
39 | RET | 1.32942515 |
40 | CSF1R | 1.32833616 |
41 | CASK | 1.31808000 |
42 | ADRBK2 | 1.28205719 |
43 | IKBKB | 1.24830246 |
44 | MAP3K3 | 1.24027463 |
45 | TSSK6 | 1.23439947 |
46 | CDK8 | 1.21116576 |
47 | LCK | 1.20127912 |
48 | JAK3 | 1.16653925 |
49 | KDR | 1.14470867 |
50 | SIK3 | 1.12333658 |
51 | CAMKK2 | 1.07494463 |
52 | MAPK13 | 1.07324542 |
53 | MAP3K13 | 1.02136621 |
54 | HCK | 1.01349726 |
55 | SIK2 | 0.99014629 |
56 | DAPK2 | 0.98598690 |
57 | ITK | 0.97552652 |
58 | MST4 | 0.97411944 |
59 | MAPK12 | 0.97080094 |
60 | TEC | 0.96116061 |
61 | PRPF4B | 0.95876843 |
62 | TAOK1 | 0.92995856 |
63 | MATK | 0.91390684 |
64 | PAK1 | 0.89802891 |
65 | JAK2 | 0.88440225 |
66 | LYN | 0.87656272 |
67 | DAPK3 | 0.86084090 |
68 | FGFR3 | 0.79614462 |
69 | PLK2 | 0.79127549 |
70 | EPHA3 | 0.78619046 |
71 | MAP3K5 | 0.77037082 |
72 | MAPKAPK5 | 0.73756344 |
73 | MAPKAPK3 | 0.73558398 |
74 | MINK1 | 0.72599358 |
75 | RPS6KA2 | 0.72092164 |
76 | NEK9 | 0.71682324 |
77 | MAP3K1 | 0.67614609 |
78 | TESK2 | 0.66329481 |
79 | NME1 | 0.65736329 |
80 | NTRK1 | 0.65623895 |
81 | GRK6 | 0.65357840 |
82 | MARK3 | 0.65106118 |
83 | BTK | 0.62862448 |
84 | PDK2 | 0.61219681 |
85 | ERN1 | 0.61030460 |
86 | PIM1 | 0.60491316 |
87 | IRAK1 | 0.59899629 |
88 | MAP2K7 | 0.59521510 |
89 | VRK1 | 0.57152383 |
90 | STK24 | 0.56706671 |
91 | ADRBK1 | 0.56137698 |
92 | TLK1 | 0.55822623 |
93 | DAPK1 | 0.54998781 |
94 | ACVR1B | 0.53037196 |
95 | BMPR2 | 0.52611219 |
96 | PDPK1 | 0.52601929 |
97 | TNK2 | 0.51624805 |
98 | PRKCD | 0.50981754 |
99 | BRAF | 0.50806031 |
100 | STK3 | 0.47681516 |
101 | HIPK2 | 0.47634437 |
102 | CSK | 0.47132218 |
103 | MOS | 0.46881945 |
104 | PRKCQ | 0.45378885 |
105 | STK4 | 0.45035956 |
106 | ABL2 | 0.43241080 |
107 | MAPK4 | 0.41743554 |
108 | CAMKK1 | 0.40776014 |
109 | MYLK | 0.40724474 |
110 | MAPK11 | 0.40676286 |
111 | CDC42BPA | 0.40567771 |
112 | FGFR4 | 0.39797810 |
113 | LRRK2 | 0.38722121 |
114 | IRAK2 | 0.37915250 |
115 | CHUK | 0.36820413 |
116 | CDK5 | 0.36086797 |
117 | STK10 | 0.34854109 |
118 | TRPM7 | 0.34718594 |
119 | CDK14 | 0.33601354 |
120 | YES1 | 0.33001763 |
121 | CLK1 | 0.32874437 |
122 | CAMK4 | 0.32193463 |
123 | PDK1 | 0.32086865 |
124 | PRKD1 | 0.31347853 |
125 | IGF1R | 0.30722796 |
126 | TAOK3 | 0.30716430 |
127 | FYN | 0.29944807 |
128 | SCYL2 | 0.29458702 |
129 | MAPKAPK2 | 0.29435129 |
130 | RAF1 | 0.29370848 |
131 | PDGFRB | 0.27154625 |
132 | EPHB1 | 0.24555463 |
133 | ABL1 | 0.24465835 |
134 | PKN1 | 0.21621484 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.01451135 |
2 | Parkinsons disease_Homo sapiens_hsa05012 | 2.54277175 |
3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.47310375 |
4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.22639468 |
5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.21539142 |
6 | Ribosome_Homo sapiens_hsa03010 | 2.10090626 |
7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.97443888 |
8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94237690 |
9 | Alzheimers disease_Homo sapiens_hsa05010 | 1.92477204 |
10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.84747324 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84612717 |
12 | Allograft rejection_Homo sapiens_hsa05330 | 1.82082402 |
13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.74040625 |
14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.70883551 |
15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.67801510 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67727909 |
17 | Phagosome_Homo sapiens_hsa04145 | 1.58870465 |
18 | Pertussis_Homo sapiens_hsa05133 | 1.57637184 |
19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.57100019 |
20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55468428 |
21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.54532259 |
22 | Lysosome_Homo sapiens_hsa04142 | 1.54285287 |
23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52262308 |
24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50372992 |
25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49698236 |
26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48939143 |
27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45519252 |
28 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.42808153 |
29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42139399 |
30 | Tuberculosis_Homo sapiens_hsa05152 | 1.40834535 |
31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40097631 |
32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37072927 |
33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35204914 |
34 | Measles_Homo sapiens_hsa05162 | 1.34189102 |
35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32247774 |
36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27077545 |
37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23677650 |
38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22006796 |
39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.21313656 |
40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20078093 |
41 | Salmonella infection_Homo sapiens_hsa05132 | 1.18950775 |
42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18283776 |
43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14196075 |
44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13655246 |
45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08966352 |
46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.07965105 |
47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07349422 |
48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07332844 |
49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06856153 |
50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05110814 |
51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04350615 |
52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00490942 |
53 | Proteasome_Homo sapiens_hsa03050 | 1.00043295 |
54 | Asthma_Homo sapiens_hsa05310 | 0.98379487 |
55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97248061 |
56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96271054 |
57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95877325 |
58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92506943 |
59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92219921 |
60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85582063 |
61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85492026 |
62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84983355 |
63 | Legionellosis_Homo sapiens_hsa05134 | 0.84773269 |
64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81129799 |
65 | Prion diseases_Homo sapiens_hsa05020 | 0.80967343 |
66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80755029 |
67 | Endocytosis_Homo sapiens_hsa04144 | 0.79465108 |
68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78714984 |
69 | Influenza A_Homo sapiens_hsa05164 | 0.78259263 |
70 | Olfactory transduction_Homo sapiens_hsa04740 | 0.77888919 |
71 | Morphine addiction_Homo sapiens_hsa05032 | 0.77638608 |
72 | Shigellosis_Homo sapiens_hsa05131 | 0.76824032 |
73 | Taste transduction_Homo sapiens_hsa04742 | 0.76550042 |
74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74699738 |
75 | Apoptosis_Homo sapiens_hsa04210 | 0.72832642 |
76 | Malaria_Homo sapiens_hsa05144 | 0.71178304 |
77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68210075 |
78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66816456 |
79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.66703801 |
80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65064733 |
81 | Platelet activation_Homo sapiens_hsa04611 | 0.64751621 |
82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63402122 |
83 | Hepatitis B_Homo sapiens_hsa05161 | 0.63196055 |
84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62132697 |
85 | GABAergic synapse_Homo sapiens_hsa04727 | 0.61452674 |
86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60540080 |
87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60437621 |
88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59446873 |
89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58971167 |
90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57909515 |
91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55944521 |
92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55810622 |
93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55049266 |
94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54542553 |
95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53644954 |
96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52735233 |
97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52359698 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52255587 |
99 | Salivary secretion_Homo sapiens_hsa04970 | 0.50919839 |
100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50675085 |
101 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.50624309 |
102 | Hepatitis C_Homo sapiens_hsa05160 | 0.49377558 |
103 | Nicotine addiction_Homo sapiens_hsa05033 | 0.49374634 |
104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48963205 |
105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48213294 |
106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45159405 |
107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44713897 |
108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43865600 |
109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42576837 |
110 | Alcoholism_Homo sapiens_hsa05034 | 0.41186712 |
111 | Glioma_Homo sapiens_hsa05214 | 0.40957251 |
112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.40897086 |
113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39884432 |
114 | Amoebiasis_Homo sapiens_hsa05146 | 0.39883014 |
115 | Long-term depression_Homo sapiens_hsa04730 | 0.39580802 |
116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38338740 |
117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38337316 |
118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38324082 |
119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35848038 |
120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35789550 |
121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34483349 |
122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33517218 |
123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33265956 |
124 | Bladder cancer_Homo sapiens_hsa05219 | 0.32910852 |
125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.30320292 |
126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29477724 |
127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28146965 |
128 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25161111 |
129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24331898 |
130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24115228 |
131 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21500413 |
132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.20602481 |
133 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19522656 |
134 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.19363555 |